The Clatterbridge Cancer Centre NHS Foundation Trust is one of the UK’s leading cancer centres
27/01/2026
This February, join and hundreds of supporters as they light up Liverpool and Chester with the Glow Green Night Walks.
📍Liverpool: Friday, 6th February 2026 | Sponsored by
📍Chester: Friday, 27th February 2026 | Sponsored by ETC
Marking World Cancer Day, these walks are an opportunity to honour local people affected by cancer, thank our staff who care for them and celebrate life-saving research happening in our region. 💚
Registration is £25 and participants are asked to raise at least £50.
Click the link in our comments and register today! 👇
26/01/2026
We've been shortlisted for a HSJ Digital Award 💻
Our Palliative Care Team has been shortlisted for the HSJ Digital Award in the Optimising Clinical Pathways through Digital category.
Their new innovative digital check‑in system is transforming how we support patients during treatment — helping the team identify who needs more care, reduce unnecessary appointments and prioritise those who are most unwell.
Last year alone, patients logged over 900 symptom scores, saving the equivalent of 40 clinics and allowing the team to give the appropriate level of care to each and every patient.
Dr Dan Monnery says the system has been “transformative for our patients and the way we deliver their care".
Congratulations to the team!
Read more via the link in the comments.
23/01/2026
If this week has convinced you it's time for a more fulfilling job, come and work for us! We've got some great opportunities available, including:
Deputy Ward Manager, Senior Diagnostic Radiographer, and Advanced Nurse Practitioner.
It’s , and we spoke with some of our Gynae Team about recognising the signs and symptoms of cervical cancer, and the importance of going for regular cervical screening.
"Cervical cancer symptoms may not always be obvious, so it's important to listen to your body and talk to your doctor if you have any concerns.
The most common symptoms to be aware of include:
- vaginal bleeding that is unusual for you, including after the menopause, after s*x, or between regular periods
- changes to vaginal discharge
- pain or discomfort during s*x
- unexplained pain in your lower back or between your hip bones and your pelvis
It's really important to go for your cervical screening when invited by the NHS.
Cervical screening saves lives. It can help stop cancer before it starts by detecting certain types of HPV (human papillomavirus) that can cause cell changes to the cervix. These cell changes are easily treated, preventing cervical cancer from developing.
If you have received an invitation for cervical screening or missed your last screening, please don’t wait – book an appointment with your GP practice now."
22/01/2026
Do you or your relative live with cancer and another health condition?
We're looking for people to participate in a Liverpool University study. Get in touch with us if you:
- Have a diagnosis of cancer and a health condition that affects how you communicate or think (for example dementia, stroke, Parkinson’s disease)
- Identify as being an ethnic minority and live in the North West
- Over the age of 18
- Are a family carer of someone who has cancer and a co-occurring condition (for example dementia, stroke, Parkinson’s disease)
For more information please call Dr Lena O’Connell on 07503792722 or email lenao@liverpool.ac.uk
21/01/2026
A big thank you to everyone who was involved in our Veganuary event at CCC-Wirral last week, and to those who kindly gave us to the opportunity to offer lots of tasty options for our staff to try 💚
21/01/2026
If you had treatment for cancer at The Clatterbridge Cancer Centre between April and June 2025, you might be invited to take part in the National Cancer Patient Experience Survey.
The survey asks cancer patients (16 years and older) about their experiences of care. Their feedback helps to improve cancer services across England.
If you had treatment with us as an inpatient or day-case and left hospital between April and June 2025, you may get a letter asking you to take part. The letter will include more information.
At The Clatterbridge Cancer Centre, we really welcome your feedback. We hope that you will complete the survey if you are asked to take part. We are keen to hear about your experience of chemotherapy (or other cancer medicines) at any of our sites, radiotherapy at our 3 main sites, our inpatient wards in Liverpool and our other services.
You can complete the survey online, on paper or over the phone. It’s also available in other languages and formats.
20/01/2026
Have you had cancer? Did you finish your initial treatment before 2024?
We invite you to tell us about the positive and negative aspects of your cancer diagnosis and treatment. By sharing your experiences, you will be joining us in helping to improve the care, treatments and services people receive.
Our Lung cancer team and Roche have been shortlisted for two national awards after demonstrating the benefits of giving patients an immunotherapy treatment subcutaneously (injected under the skin) instead of intravenously.
They are finalists in the ‘Best Contribution to Improving the Efficiency of NHS services’ and the ‘Best Pharmaceutical Partnership with the NHS’ categories.
CCC was one of the first hospitals in the North West to roll out the subcutaneous version for lung cancer, benefiting patients and the NHS by reducing treatment time while maintaining quality.
The collaboration with Roche is the first real-world study of its kind and used time-stamped data to show that giving the treatment by injection under the skin significantly reduced the time each patient spends on chemotherapy treatment units by an average of 54 minutes each time. It is also far more efficient for hospitals, meaning more patients can treated and there is less drug wastage.
Hala Ghoz, Advanced Clinical Practitioner in Lung Cancer, said:
“The Clatterbridge Cancer Centre is a national leader in immunotherapy treatment innovation and we quickly recognised the potential benefits of subcutaneous options for our patients and for the NHS as a whole.
“The subcutaneous treatment takes just 7 minutes to administer, compared with 30 to 60 minutes for the intravenous version. Patients find it more convenient as they spend less time in hospital. The NHS benefits from this increased capacity and it has also reduced wastage.”
Lung Cancer Advanced Nurse Practitioner Sarah Rose said:
“We know that our patients really value spending less time in hospital, and we hope that by adopting these new treatment methods that we can make life easier and less complicated for them.”
Our Metastatic Breast Cancer team and Novartis have also been shortlisted for the ‘Best Pharmaceutical Partnership with the NHS’ award for their pioneering work supporting patients with treatment-related toxicities (side-effects).
Both teams will find out whether they have won at an awards ceremony on 19 March 2026. The HSJ Partnership Awards recognise collaborations between industry and the NHS.
14/01/2026
Our Radiotherapy Teams held a festive bake off across our three sites in December, and after some close competition, have crowned their winner - pictured here receiving her apron and a congratulatory handshake 👩🍳
There was a fantastic range of bakes on display, showcasing both creativity and enthusiasm across the teams. Thank you to everyone who got involved!
Be the first to know and let us send you an email when The Clatterbridge Cancer Centre posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
The Clatterbridge Cancer Centre NHS Foundation Trust is one of the UK’s leading cancer centres providing highly specialist cancer care to a population of 2.3m people across Cheshire, Merseyside and the surrounding areas including the Isle of Man.
We are based in Wirral, Merseyside supported by a £17m radiotherapy treatment centre in Aintree, Liverpool. We also operate specialist chemotherapy clinics in seven of Merseyside’s district hospitals and deliver a pioneering Treatment at Home service.
Together, this enables us to provide a comprehensive range of inpatient care, advanced radiotherapy, chemotherapy and other systemic anti-cancer therapies (i.e. medicines) including gene therapies and immunotherapies. We are also the only facility in the UK providing low-energy proton beam therapy to treat rare eye cancers and host the region’s Teenage and Young Adult Unit, (supported by the Teenage Cancer Trust).
We are a tertiary cancer centre which means we see patients who have already been diagnosed and referred to us by other hospitals. We provide non-surgical cancer care e.g. chemotherapy and radiotherapy for solid tumours and blood cancers.
Our services include:
Academic oncology – professors and senior clinical lecturers appointed jointly with the University of Liverpool
Acute oncology – specialist cancer support in A&E and acute care in other hospitals
Chemotherapy and other systemic anti-cancer treatments (SACT). These are drug treatments for cancer and include gene therapies, immunotherapies and other molecular agents
Haemato-oncology – in July 2017 the management of the Royal Liverpool University Hospital’s Haemato-oncology service transferred to The Clatterbridge Cancer Centre. This service provides inpatient and outpatient care for acute leukaemia; chronic leukaemia; lymphoma; myeloma and bone marrow (stem cell) transplant
Eye proton therapy – we have the UK’s only low-energy proton beam therapy facility for treating rare eye tumours
Imaging and pre-treatment radiotherapy (diagnostic imaging / treatment planning) – we have PET-CT, CT, MRI, x-ray facilities and treatment planning
Inpatient wards – we have 73 inpatient beds across our three wards on our Wirral site
Pharmacy – we manufacture all the chemotherapy doses for solid tumour cancers in Cheshire & Merseyside
Physics – our physicists provide essential scientific support for radiotherapy treatment
Radiotherapy – we have 10 linear accelerators (radiotherapy treatment machines). Six at the Wirral site; three at the Aintree site; one in the Clatterbridge Private Clinic
Research & development – we carry out leading-edge clinical trials of new cancer treatments. Our BioBank of donated tissue provides a valuable resource for cancer researchers
Supportive care – including physiotherapy, psychological support, palliative care, speech and language therapy, occupational therapy, dietetics, cancer information, financial / benefits advice, and survivorship / living with and beyond cancer
Triage & assessment – we provide rapid-access assessment clinics and 24-hour phone support for patients who need urgent advice or care while having cancer treatment
We are expanding and improving cancer care even further with the development of a new 11-floor specialist cancer hospital in the heart of Liverpool. The new cancer hospital is due to open in 2020 and will provide highly-specialist cancer care for people with blood cancers and solid tumours. Although the Liverpool hospital will become our main base, we will also continue providing services at our current site in Wirral and our satellite radiotherapy centre on the Aintree site.
Being located in central Liverpool alongside the University of Liverpool and Royal Liverpool University Hospital will significantly improve care for people with cancer:
Our main base will be closer to the majority of the population we serve, which stretches from Southport down to Wirral and across to Widnes / Warrington. People who live closer to Wirral / Aintree will still be able to access care locally as we’re keeping our current sites
Unlike now, we will be co-located with a major acute teaching hospital providing rapid access to intensive care and other key medical and surgical specialties when patients need them. At the moment these patients have to be transferred by emergency ambulance to other hospitals
We will be at the heart of a thriving research and healthcare campus with the University of Liverpool, NHS and other key research partners, enabling even more ground breaking cancer research and clinical trials.
You can find out more about the new building here.
